Evidence map›Paper›PMID 25337923›Full record

ArticleThe Journal of clinical endocrinology and metabolism2015

The level of circulating octanoate does not predict ghrelin O-acyl transferase (GOAT)-mediated acylation of ghrelin during fasting.

Ralf Nass, Alexander Nikolayev, Jianhua Liu, Suzan S Pezzoli, Leon S Farhy, James Patrie, Bruce D Gaylinn, Mark Heiman, Michael O Thorner

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ralf NassDivision of Endocrinology and Metabolism (R.N., J.L., S.S.P., L.S.F., B.D.G., M.O.T.), Department of Medicine, Center for Diabetes Technology (L.S.F.), and Department of Health Sciences (J.P.), University of Virginia, Charlottesville, Virginia 22908; and Eli Lilly (A.N., M.H.), Lilly Research Laboratories, Indianapolis, Indiana 46285.
Alexander Nikolayev
Jianhua Liu
Suzan S Pezzoli
Leon S Farhy
James Patrie
Bruce D Gaylinn
Mark Heiman
Michael O Thorner
University of Virginia · USEli Lilly (United States) · US

Funding

ZACOPRIDE VS METOCLOPRAMIDE--EFFECT ON LOWER ESOPHAGEAL SPHINCTERM01RR000847 · NCRR · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI ALTES, TALISSA A · 1985 to 2010
$48.1M
Ghrelin Regulation: Implications for Understanding ObesityR01DK076037 · NIDDK · UNIVERSITY OF VIRGINIA · PI THORNER, MICHAEL O · 2008 to 2012
$2.7M
Pancreatic endocrine network control of glucagon counterregulationR01DK082805 · NIDDK · UNIVERSITY OF VIRGINIA · PI FARHI, LEON S, MCCALL, ANTHONY L · 2010 to 2013
$1.3M
STUDIES WITH GROWTH HORMONE RELEASING FACTORR01DK032632 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI THORNER, MICHAEL O · 1986 to 2002
$1.2M
Regulation of GhrelinK23RR018770 · NCRR · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI NASS, RALF M · 2005 to 2009
$657k
NCRR NIH HHS K23 RR018770NCRR NIH HHS K23RR018770NCRR NIH HHS M01 RR000847NCRR NIH HHS M01 RR00847NIDDK NIH HHS 1R01DK076037NIDDK NIH HHS 1R01DK32632NIDDK NIH HHS R01 DK076037NIDDK NIH HHS R01 DK082805NIDDK NIH HHS R01DK082805
6 · The paper itself

Abstract

backgroundAcyl-ghrelin is a 28-amino acid peptide released from the stomach. Ghrelin O-acyl transferase (GOAT) attaches an 8-carbon medium-chain fatty acid (MCFA) (octanoate) to serine 3 of ghrelin. This acylation is necessary for the activity of ghrelin. Animal data suggest that MCFAs provide substrate for GOAT and an increase in nutritional octanoate increases acyl-ghrelin.

objectivesTo address the question of the source of substrate for acylation, we studied whether the decline in ghrelin acylation during fasting is associated with a decline in circulating MCFAs.

methodsEight healthy young men (aged 18-28 years, body mass index range, 20.6-26.2 kg/m(2)) had blood drawn every 10 minutes for acyl- and desacyl-ghrelin and every hour for free fatty acids (FFAs) during the last 24 hours of a 61.5-hour fast and during a fed day. FFAs were measured by a highly sensitive liquid chromatography-mass spectroscopy method. Acyl- and desacyl-ghrelin were measured in an in-house assay; the results were published previously. Ghrelin acylation was assessed by the ratio of acyl-ghrelin to total ghrelin.

resultsWith the exception of MCFAs C8 and C10, all other FFAs, the MCFAs (C6 and C12), and the long-chain fatty acids (C14-C18) significantly increased with fasting (P < .05). There was no significant association between the fold change in ghrelin acylation and circulating FFAs.

conclusionsThese results suggest that changes in circulating MCFAs are not linked to the decline in ghrelin acylation during fasting and support the hypothesis that acylation of ghrelin depends at least partially on the availability of gastroluminal MCFAs or the regulation of GOAT activity.

Indexed as

AcylationAcyltransferasesAdolescentAdultCaprylatesFastingFatty Acids, NonesterifiedGhrelinHumansMaleYoung AdultAcyltransferasesCaprylatesFatty Acids, NonesterifiedGhrelinMBOAT4 protein, humanoctanoic acid

Identifiers

PMID25337923
PMCPMC4283022
OpenAlexW2104857321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.